Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of...

3
Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical and humanistic outcomes - Diabetes, hypertension, gout, mental health, HIV/AIDS, gout… - Novel pharmacy practice models Health Related Quality of Life (HRQOL) - Develop and assess instruments for clinical trials and practice - Gout Impact Scale (GIS) in multinational clinical trials for new therapies - Student Quality of Life, Stress, & Coping Skills

Transcript of Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of...

Page 1: Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Jan D. Hirsch, BS Pharm, PhDResearch Interests

Pharmacoeconomics & Outcomes Research

“Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical and humanistic outcomes - Diabetes, hypertension, gout, mental health, HIV/AIDS, gout… - Novel pharmacy practice models

Health Related Quality of Life (HRQOL) - Develop and assess instruments for clinical trials and

practice - Gout Impact Scale (GIS) in multinational clinical trials for

new therapies - Student Quality of Life, Stress, & Coping Skills

Page 2: Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Core Expertise

Assessing Patient Reported Outcomes (PROs)- Patient/subject perceptions, attitudes, knowledge, intentions, symptoms- Health Related Quality of Life (HRQOL)

Instrument development and validationAssessment across patient groups, countries, cultures

Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions

Pre-market “value” of new pharmaceuticals- Economic, clinical and humanistic value propositions

- Given current and likely future market conditions- Evidence required for reimbursement by payers all countries- Pharmacoeconomic research strategy and plan to collect and

disseminate needed data

Page 3: Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Proposed Collaborations with SSPPS Faculty

Assessing Patient Reported Outcomes (PROs)- Patient/subject perceptions, attitudes, knowledge, intentions, symptoms- Health Related Quality of Life (HRQOL)

Instrument development and validationAssessment across patient groups, countries, cultures

Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions

Pre-market “value” of new pharmaceuticals- Economic, clinical and humanistic value propositions

- Given current and likely future market conditions- Evidence required for reimbursement by payers all countries- Pharmacoeconomic research strategy and plan to collect and

disseminate needed data

Clin

ical

Fac

ulty

Pha

rm S

cien

ces